Open Orphan (LON:ORPH) Trading 5.3% Higher – What’s Next?
by Mitch Edgeman · The Markets DailyOpen Orphan Plc (LON:ORPH – Get Free Report)’s stock price was up 5.3% during mid-day trading on Tuesday . The company traded as high as GBX 10.38 ($0.13) and last traded at GBX 10 ($0.13). Approximately 652,639 shares changed hands during trading, a decline of 58% from the average daily volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Stock Performance
The company has a quick ratio of 1.16, a current ratio of 1.19 and a debt-to-equity ratio of 10.88. The company has a fifty day moving average price of GBX 10 and a 200 day moving average price of GBX 10. The stock has a market cap of £67.09 million and a PE ratio of -25.30.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Articles
- Five stocks we like better than Open Orphan
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- What is a Dividend King?
- Tesla Stock: Buy the Dips, Sell the Rips